Kancera AB

Suède


Commandez votre montre hebdomadaire Kancera AB
Quantité totale PI 33
Rang # Quantité totale PI 43 995
Note d'activité PI 2,2/5.0    19
Rang # Activité PI 43 323
Symbole boursier
ISIN SE0015658570
Capitalisation 127.200005M  (SEK)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

15 0
4 0
12 1
1
 
Dernier brevet 2025 - Process for the steroselective p...
Premier brevet 2006 - 5,7-disubstituted thiazolo[4,5-d...
Dernière marque 2025 - NOVAKAND
Première marque 2025 - NOVAKAND

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 P/S Medicinal preparations and substances; Pharmaceutical preparations and substances; Pharmaceutical...
Invention Process for the steroselective preparation of chiral 2-[(hetero)arylalkylsulfanyl]pyrimidines and...
2024 Invention Fractalkine receptor antagonists for use in the prevention of thrombus formation and/or growth. T...
Invention New use. There is provided herein a compound of formula I, or pharmaceutically acceptable salt t...
2023 Invention Process for the stereoselective preparation of chiral 2-[(hetero) arylalkylsulfanyl]pyrimidines a...
2022 Invention Process for the stereoselective preparation of chiral 2-[(hetero)arylalkylsulfanyl]pyrimidines an...
2021 Invention N-hydroxycarboxamide derivatives useful as inhibitors of mammalian histone deacetylase activity. ...
Invention Phosphate and phosphonate derivatives of 7-amino-5-thio-thiazolo[4,5-d]pyrimidines and their use ...
Invention New treatments of viral infections. There is provided a compound of formula (I), wherein R1,R2, Q...
Invention 2-phenylimidazo[4,5-b]pyridin-7-amine derivates useful as inhibitors of mammalian tyrosine kinase...
2019 Invention Process for the steroselective preparation of chiral 2- [(hetero)arylalkylsulfanyl] pyrimidines a...
Invention A process for the stereoselective preparation of chiral 2-[(hetero)arylalkylsulfanyl]pyrimidines ...
2016 Invention Bicyclic hydroxamic acids useful as inhibitors of mammalian histone deacetylase activity. A compo...
Invention Bisarylsulfonamides useful in the treatment of inflammation and cancer. A compound of formula (I)...
Invention 2-phenyl-3h-imidazo[4,5-b]pyridine derivates useful as inhibitors of mammalian tyrosine kinase ro...
2015 Invention Benzimidazole derivates useful as inhibitors of mammalian histone deacetylase activity. A compoun...
2011 Invention Antibodies against ror1 and uses thereof. The invention relates to antibodies for inducing cell d...
Invention Sulfonamide compounds. A compound of formula (I), wherein A is S, O or a double bond, and L is a ...
Invention Bisarylsulfonamides useful as kinase inhibitors in the treatment of inflammation and cancer. A co...
P/S Medicines for dental purposes; medicines for human purposes; medicines for veterinary purposes; ...
2010 Invention 5,7-disubstituted thiazolo[4,5-d]pyrimidines as chemokine inhibitors. 3CR1 receptor antagonists a...
Invention Biological inhibitors of ror1 capable of inducing cell death. The invention relates to antibodies...
2007 Invention 5,7-disubstituted thiazolo[4,5-d]pyrimidines for the selective inhibition of chemokine receptors....